A Low-Molecular-Weight Phenotype of Apolipoprotein(a) as a Factor Provoking Accumulation of Cholesterol by THP-1 Monocyte-Like Cells
- 4 Downloads
Increased concentration of lipoprotein(a) is a risk factor of coronary heart disease. lipoprotein(a) consists of LDL-like and highly polymorphic apolipoprotein(a). Here we studied the effect of lipoprotein(a)-containing sera with different apolipoprotein(a) phenotypes on lipid accumulation by THP-1 monocyte-like cells. Cholesterol concentration in lysates of THP-1 cells was significantly higher after their incubation with lipoprotein(a)-containing serum samples with low-molecular-weight phenotype of apolipoprotein(a) in comparison with samples with a high-molecular-weight apolipoprotein(a) phenotype irrespective of initial cholesterol level as well as serum concentrations of apoB-100, oxidized LDL, and circulating immune complexes. The presence of the most atherogenic small dense LDL subfractions in examined sera in addition to a low-molecular-weight apolipoprotein(a) phenotype resulted in significant elevation of cholesterol accumulation by THP-1 cells. The data obtained explain greater atherogenicity of lipoprotein(a) with low-molecular-weight apolipoprotein(a) phenotype.
Key Wordslipoprotein(a) apo(a) phenotype macrophages THP-1 cells lipoprotein subfractions
Unable to display preview. Download preview PDF.
- 1.Afanas’eva OI, Adamova IYu, Benevolenskaya GF, Pokrovskii SN. Enzyme immunoassay of lipoprotein(a). Bull. Exp. Biol. Med. 1995;120(4):1030-1033.Google Scholar
- 2.Afanasyeva OI, Ezhov MV, Safarova MS, Afanasyeva MI, Adamova IYu, Pokrovsky SN. Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women. Kardiovask. Ter. Prof. 2010;9(6):10-16. Russian.Google Scholar
- 3.Afanasieva OI, Utkina EA, Artemieva NV, Ezhov MV, Adamova IYu, Pokrovsky SN. Elevated Lipoprotein(a) Concentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease. Kardiologiya 2016;56(6):5-11. Russian.CrossRefGoogle Scholar
- 7.Dieplinger B, Lingenhel A, Baumgartner N, Poelz W, Dieplinger H, Haltmayer M, Kronenberg F, Mueller T. Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Clin. Chem. 2007;53(7):1298-1305.CrossRefGoogle Scholar
- 12.Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A; European Atherosclerosis Society Consensus Panel. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur. Heart J. 2010;31(23):2844-2853.CrossRefGoogle Scholar